Combined GHRP-2 + GHRH Sustainably Elevates GH and IGF-1 in Healthy Older Adults
Combined subcutaneous GHRP-2 + GHRH infusion sustained pulsatile GH secretion and elevated IGF-1 and IGFBP-3 in healthy older adults with gender-specific synergy — women showed greater response than men.
Quick Facts
What This Study Found
Combined SC GHRP-2 + GHRH infusion sustainably elevated pulsatile GH, IGF-1, and IGFBP-3 in healthy older adults without desensitization, with synergy exceeding individual effects and women showing greater response than men.
Key Numbers
How They Did This
Clinical trial in healthy older adults. SC infusion of combined GHRP-2 + GHRH. GH profiling (deconvolution analysis), IGF-1, IGFBP-3 measured. Gender comparison. Synergy versus individual peptide effects assessed.
Why This Research Matters
Age-related GH decline affects millions. A sustained, synergistic peptide combination that restores youthful GH patterns without desensitization could transform anti-aging endocrinology.
The Bigger Picture
The combination of GHRP + GHRH is the most effective physiological approach to restoring GH secretion in aging — hitting both the accelerator and releasing the brake simultaneously.
What This Study Doesn't Tell Us
Short-term SC infusion study. Long-term chronic infusion effects need assessment. SC infusion is less practical than oral or daily injection dosing.
Questions This Raises
- ?Can the synergistic effect be achieved with intermittent dosing?
- ?Why do women respond more than men?
- ?Could this combination prevent age-related muscle and bone loss?
Trust & Context
- Key Stat:
- Sustained without fade Combined GHRP-2 + GHRH maintained elevated pulsatile GH and IGF-1 without desensitization in older adults — sustainable anti-aging hormone restoration
- Evidence Grade:
- Strong evidence from a well-designed clinical trial with intensive hormonal profiling and gender comparison in the target elderly population.
- Study Age:
- Published in 2004. Combined GHRP + GHRH remains the gold standard for research on restoring the aging GH axis.
- Original Title:
- Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
- Published In:
- The Journal of clinical endocrinology and metabolism, 89(5), 2290-300 (2004)
- Authors:
- Bowers, Cyril Y(20), Granda, Ramona, Mohan, Subburaman, Kuipers, Jonathan, Baylink, David, Veldhuis, Johannes D
- Database ID:
- RPEP-00887
Evidence Hierarchy
Frequently Asked Questions
Can GH decline with aging be reversed?
This study shows combined GHRP-2 + GHRH sustainably restores youthful GH secretion patterns in older adults — without the response fading over time. It's the most effective approach tested for aging GH restoration.
Do men and women respond differently?
Yes — women showed greater GH response to the combination. This gender difference is important for dosing and may relate to estrogen's protective effects on the GH axis.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00887APA
Bowers, Cyril Y; Granda, Ramona; Mohan, Subburaman; Kuipers, Jonathan; Baylink, David; Veldhuis, Johannes D. (2004). Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.. The Journal of clinical endocrinology and metabolism, 89(5), 2290-300.
MLA
Bowers, Cyril Y, et al. "Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.." The Journal of clinical endocrinology and metabolism, 2004.
RethinkPeptides
RethinkPeptides Research Database. "Sustained elevation of pulsatile growth hormone (GH) secreti..." RPEP-00887. Retrieved from https://rethinkpeptides.com/research/bowers-2004-sustained-elevation-of-pulsatile
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.